Bayer AG - Stockholders' Newsletter Third Quarter 2007 - Bayer Group Consolidated Balance Sheets

2 of 6

Financial Statements

Bayer Group Consolidated Balance Sheets

	Sept. 30, 2006	Sept. 30, 2007	Dec. 31, 2006
€ million
Noncurrent assets
Goodwill	8,796	8,336	8,227
Other intangible assets	14,801	14,685	15,807
Property, plant and equipment	9,357	8,664	8,867
Investments in associates	655	481	532
Other financial assets	1,084	1,104	1,094
Other receivables	201	488	176
Deferred taxes	1,283	808	1,205
	36,177	34,566	35,908
Current assets
Inventories	7,123	6,315	6,153
Trade accounts receivable	6,512	6,331	5,802
Other financial assets	677	312	401
Other receivables	1,490	1,548	1,567
Claims for income tax refunds	218	240	220
Cash and cash equivalents	2,907	2,381	2,915
Assets held for sale and discontinued operations	1,654	0	2,925
	20,581	17,127	19,983

Total assets	56,758	51,693	55,891

Stockholders’ equity
Capital stock of Bayer AG	1,957	1,957	1,957
Capital reserves of Bayer AG	4,028	4,028	4,028
Other reserves	6,697	10,937	6,782
	12,682	16,922	12,767
Equity attributable to minority interest	482	86	84
	13,164	17,008	12,851

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	7,043	5,268	6,543
Other provisions	1,514	1,596	1,464
Financial liabilities	14,447	13,307	14,723
Other liabilities	558	502	449
Deferred taxes	3,988	3,632	4,346
	27,550	24,305	27,525
Current liabilities
Other provisions	4,280	4,080	3,765
Financial liabilities	7,361	1,298	5,078
Trade accounts payable	1,992	2,217	2,369
Income tax liabilities	144	104	109
Other liabilities	1,898	2,681	3,346
Liabilities directly related to assets held for sale and discontinued operations	369	-	848
	16,044	10,380	15,515

Total stockholders’ equity and liabilities	56,758	51,693	55,891